Voyager Acquisition Corp.
Status: Live Deal
U=S+W/2 W=S@11.50
IPO Proceeds, $M $253.00M
IPO Date Aug 9, 2024
CEO Adeel Rouf
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.5%
SPAC Tenor 24 months
IPO Sector Healthcare
IPO Geography Global
Target Company VERAXA Biotech
Deal Announced Apr 23, 2025
Deal Size, $M $1,382.30M
Deal Sector Healthcare
Deal Geography Europe
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote TBD
VACH VACHU VACHW

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.